These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 30454704

  • 1. Leukocytic toll-like receptor 2 knockout protects against diabetes-induced cardiac dysfunction.
    Lei L, Hu H, Lei Y, Feng J.
    Biochem Biophys Res Commun; 2018 Nov 30; 506(3):668-673. PubMed ID: 30454704
    [Abstract] [Full Text] [Related]

  • 2. Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis.
    Kain V, Kumar S, Sitasawad SL.
    Cardiovasc Diabetol; 2011 Nov 04; 10():97. PubMed ID: 22054019
    [Abstract] [Full Text] [Related]

  • 3. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes.
    Norby FL, Wold LE, Duan J, Hintz KK, Ren J.
    Am J Physiol Endocrinol Metab; 2002 Oct 04; 283(4):E658-66. PubMed ID: 12217882
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of advanced glycation endproduct (AGE) rescues against streptozotocin-induced diabetic cardiomyopathy: Role of autophagy and ER stress.
    Pei Z, Deng Q, Babcock SA, He EY, Ren J, Zhang Y.
    Toxicol Lett; 2018 Mar 01; 284():10-20. PubMed ID: 29174818
    [Abstract] [Full Text] [Related]

  • 5. Transgenic overexpression of insulin-like growth factor I prevents streptozotocin-induced cardiac contractile dysfunction and beta-adrenergic response in ventricular myocytes.
    Norby FL, Aberle NS, Kajstura J, Anversa P, Ren J.
    J Endocrinol; 2004 Jan 01; 180(1):175-82. PubMed ID: 14709156
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Metallothionein alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of Ca2+ cycling proteins, NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chain isozyme.
    Wold LE, Ceylan-Isik AF, Fang CX, Yang X, Li SY, Sreejayan N, Privratsky JR, Ren J.
    Free Radic Biol Med; 2006 Apr 15; 40(8):1419-29. PubMed ID: 16631532
    [Abstract] [Full Text] [Related]

  • 9. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.
    Huang R, Shi Z, Chen L, Zhang Y, Li J, An Y.
    Eur J Pharmacol; 2017 Nov 05; 814():151-160. PubMed ID: 28826911
    [Abstract] [Full Text] [Related]

  • 10. [Cardiac metallothionein overexpression improves cardiac contractile function and attenuates oxidative stress in lipopolysaccharide-treated mice].
    Zhao P, Zhang J, Chu X, Yuan HT, Cui LQ, Zhu XL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug 05; 39(8):711-6. PubMed ID: 22169416
    [Abstract] [Full Text] [Related]

  • 11. High-dose benfotiamine rescues cardiomyocyte contractile dysfunction in streptozotocin-induced diabetes mellitus.
    Ceylan-Isik AF, Wu S, Li Q, Li SY, Ren J.
    J Appl Physiol (1985); 2006 Jan 05; 100(1):150-6. PubMed ID: 16166234
    [Abstract] [Full Text] [Related]

  • 12. Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis.
    Sun X, Chen RC, Yang ZH, Sun GB, Wang M, Ma XJ, Yang LJ, Sun XB.
    Food Chem Toxicol; 2014 Jan 05; 63():221-32. PubMed ID: 24269735
    [Abstract] [Full Text] [Related]

  • 13. Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.
    Prakoso D, De Blasio MJ, Tate M, Kiriazis H, Donner DG, Qian H, Nash D, Deo M, Weeks KL, Parry LJ, Gregorevic P, McMullen JR, Ritchie RH.
    Am J Physiol Heart Circ Physiol; 2020 Apr 01; 318(4):H840-H852. PubMed ID: 32142359
    [Abstract] [Full Text] [Related]

  • 14. Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy.
    Umbarkar P, Singh S, Arkat S, Bodhankar SL, Lohidasan S, Sitasawad SL.
    Free Radic Biol Med; 2015 Oct 01; 87():263-73. PubMed ID: 26122707
    [Abstract] [Full Text] [Related]

  • 15. [Effects of yellow wine polyphenols on cardiomyocyte apoptosis in diabetic cardiomyopathy rats].
    Pan SL, Lin H, Luo HQ, Gao FD, Meng LP, Guo Y, Guo HY, Chi JF.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 May 08; 33(5):431-435. PubMed ID: 29926588
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Overexpression of human C-reactive protein exacerbates left ventricular remodeling in diabetic cardiomyopathy.
    Mano Y, Anzai T, Kaneko H, Nagatomo Y, Nagai T, Anzai A, Maekawa Y, Takahashi T, Meguro T, Yoshikawa T, Fukuda K.
    Circ J; 2011 May 08; 75(7):1717-27. PubMed ID: 21519150
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.
    De Blasio MJ, Huynh K, Qin C, Rosli S, Kiriazis H, Ayer A, Cemerlang N, Stocker R, Du XJ, McMullen JR, Ritchie RH.
    Free Radic Biol Med; 2015 Oct 08; 87():137-47. PubMed ID: 25937176
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.